This inventor holds 1 USPTO granted patent. Top assignees: Sekisui Medical Co., Ltd., Toyo Boseki Kabushiki Kaisha. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2013
Title: Takeshi Miyata: Pioneer in L-Amino Acid Production
Introduction: Takeshi Miyata, an innovative inventor hailing from Hachimantai, Japan, has made significant contributions to the field of biochemistry. With a focus on improving the production of amino acids, Miyata's work is valuable, especially in pharmaceuticals. His singular patent reflects his commitment to advancing scientific research and application.
Latest Patents: Takeshi Miyata holds a notable patent for "L-succinylaminoacylase and process for producing L-amino acid using it." This invention provides an L-aminoacylase capable of producing L-tert-leucine, which serves as an important intermediate in pharmaceutical applications. The patent details various characteristics of the protein, including specific amino acid sequences and conditions under which the enzyme operates, demonstrating Miyata's expert understanding of molecular biochemistry.
Career Highlights: Throughout his career, Takeshi Miyata has worked with esteemed companies such as Toyo Boseki and Sekisui Medical Co., Ltd. His experiences in these organizations have allowed him to apply his innovative ideas in practical settings, fostering advancements in the industry.
Collaborations: Miyata has collaborated with notable coworkers, including Atsushi Toda and Sachio Iwai. Their combined expertise contributes to the rich collaborative spirit often necessary for success in research and innovation.
Conclusion: In summary, Takeshi Miyata stands out as a prominent inventor dedicated to the realm of amino acid production. His pioneering patent not only underscores his innovative capabilities but also highlights the importance of collaboration in research and development. As the fields of biochemistry and pharmaceuticals evolve, Miyata's contributions will undoubtedly leave a lasting impact.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile